| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Chief Accounting Officer | VP - Finance
2 companies
Lerner Neil serves as a Chief Accounting Officer at CMPX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 4 buys and 5 sells. Those positions are worth an estimated $386K at current prices.
The biggest single holding is CMPX (~$386K) as Chief Accounting Officer. Net of sales, the recent Form 4 record there shows accumulation of 42,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | CMPX Compass Therapeutics, Inc. | Chief Accounting Officer | Buy | 20,000 | $0.92 | $18,400.00 | +5.0% | - | - | |
| Sep 24, 2026 | CMPX Compass Therapeutics, Inc. | Chief Accounting Officer | Buy | 2,500 | $1.14 | $2,850.00 | +0.6% | - | - | |
| Apr 7, 2025 | CMPX Compass Therapeutics, Inc. | Chief Accounting Officer | Buy | 20,000 | $1.42 | $28,400.00 | +6.7% | +68.2% | +238.2% | |
| Mar 12, 2019 | PMDI Psychemedics Corp | VP - Finance | Sell | 9,057 | $15.10 | $136,780.67 | -40.7% | - | - | |
| May 22, 2018 | PMDI Psychemedics Corp | VP - Finance | Sell | 4,892 | $20.08 | $98,243.03 | -18.0% | - | - | |
| Nov 18, 2016 | PMDI Psychemedics Corp | VP - Finance | Sell | 3,000 | $24.75 | $74,250.00 | -10.4% | - | - | |
| Sep 10, 2015 | PMDI Psychemedics Corp | VP - Finance | Buy | 3,000 | $10.32 | $30,960.00 | +11.1% | - | - |